Deepak Nitrite Q2 & H1 FY26 Earnings Call Transcript
Deepak Nitrite releases Q2 & H1 FY26 earnings call transcript, reporting ₹1,922 crore revenue, ₹224 crore EBITDA. Phenolics grew, Advanced Intermediates faced headwinds. New hydrogenation asset & R&D center inaugurated.
The earnings call transcript provides insights into the company's performance and future strategies, which can influence investor decisions and market perception.
The announcement is a factual update on the earnings call transcript and financial performance, without any strong positive or negative outlook.
* Deepak Nitrite Limited has released the transcript of its Q2 & H1 FY26 earnings conference call held on 14 Nov 2025. * The company reported consolidated revenues of ₹1,922 crore in Q2 FY26, with a consolidated EBITDA of ₹224 crore. * The Phenolics business saw a revenue growth of 2% sequentially, with a 23% improvement in EBIT. Record quarterly production and sales of Isopropyl Alcohol were achieved. * The Advanced Intermediates segment faced headwinds from tariff actions and underpriced imports, but maintained a stable top line by pivoting to non-traditional geographies. * Commencement of hydrogenation asset at Deepak Chem Tech with an investment of about ₹118 crore and inauguration of R&D center at Savli with an investment of about ₹100 crore. * The company's Nitric Acid as well as MIBK/MIBC plants are expected to be commissioned soon. * Domestic business revenue stood at ₹1,632 crore and export revenues were ₹270 crore in Q2 FY26. * ROCE is reported at 14% with net worth of ₹5,550 crore and debt-to-equity of 0.21.
What to do with a filing like this
Deepak Nitrite Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Deepak Nitrite Limited. Read the original for the full detail.